Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 2 (2005), Issue 2 (February)

1. Time to remission and relapse after the first hospital admission in severe bipolar disorder.
   Soc Psychiatry Psychiatr Epidemiol, 40(2): 106-13. [Abstract] [Full-text]
2. Incidence of bipolar affective disorder in three UK cities: results from the AESOP study.
   Br J Psychiatry, 186: 126-31. [Abstract] [Full-text]
3. Impact of childhood abuse on the clinical course of bipolar disorder.
   Br J Psychiatry, 186: 121-5. [Abstract] [Full-text]
4. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
   Int J Neuropsychopharmacol, 7(4): 507-22. [Abstract] [Full-text]
5. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
   Int J Neuropsychopharmacol, 7(4): 387-90. [Abstract] [Full-text]
6. Processing efficiency and sustained attention in bipolar disorder.
   J Int Neuropsychol Soc, 11(1): 49-57. [Abstract] [Full-text]
7. Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association at CUX2 and FLJ32356.
   Am J Med Genet B Neuropsychiatr Genet, 132(1): 38-45. [Abstract] [Full-text]
8. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.
   Biol Psychiatry, 57(3): 252-60. [Abstract] [Full-text]
9. Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium.
   Schizophr Res, 74(1): 111-9. [Abstract] [Full-text]
10. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.
    Neurosci Lett, 376(1): 51-5. [Abstract] [Full-text]
11. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(2): 283-90. [Abstract] [Full-text]
12. Mixed depression: a clinical marker of bipolar-II disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(2): 267-74. [Abstract] [Full-text]
13. Increased levels of glucocorticoid receptors and enhanced glucocorticoid receptor auto-regulation after hydrocortisone challenge in B-lymphoblastoids from patients with affective disorders.
    Psychoneuroendocrinology, 30(4): 325-32. [Abstract] [Full-text]
14. Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting.
    Psychiatry Res, 133(1): 73-80. [Abstract] [Full-text]
15. Co-existence of lycanthropy and Cotard's syndrome in a single case.
    Acta Psychiatr Scand, 111(3): 250-2; discussion 252. [Abstract] [Full-text]
16. Staying well with bipolar disorder.
    Aust N Z J Psychiatry, 39(3): 187-93. [Abstract] [Full-text]
17. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.
    Proc Natl Acad Sci U S A, 102(6): 2152-7. [Abstract] [Full-text]
18. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.
    Biol Psychiatry, 57(4): 430-2. [Abstract] [Full-text]
19. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania.
    J Affect Disord, 84(2): 279-90. [Abstract] [Full-text]
20. Sensitivity and specificity of a new bipolar spectrum diagnostic scale.
    J Affect Disord, 84(2): 273-7. [Abstract] [Full-text]
21. Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series.
    J Affect Disord, 84(2): 267-72. [Abstract] [Full-text]
22. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    J Affect Disord, 84(2): 259-66. [Abstract] [Full-text]
23. A closer look at treatment resistant depression: is it due to a bipolar diathesis?
    J Affect Disord, 84(2): 251-7. [Abstract] [Full-text]
24. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    J Affect Disord, 84(2): 243-9. [Abstract] [Full-text]
25. Is migraine in unipolar depressed patients a bipolar spectrum trait?
    J Affect Disord, 84(2): 233-42. [Abstract] [Full-text]
26. A downscaled practical measure of mood lability as a screening tool for bipolar II.
    J Affect Disord, 84(2): 225-32. [Abstract] [Full-text]
27. Temperament in the clinical differentiation of depressed bipolar and unipolar major depressive patients.
    J Affect Disord, 84(2): 219-23. [Abstract] [Full-text]
28. Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?
    J Affect Disord, 84(2): 209-17. [Abstract] [Full-text]
29. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    J Affect Disord, 84(2): 197-207. [Abstract] [Full-text]
30. Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression.
    J Affect Disord, 84(2): 187-96. [Abstract] [Full-text]
31. High rate of unrecognized bipolar mixed states among destitute Hispanic adolescents referred for "major depressive disorder".
    J Affect Disord, 84(2): 179-86. [Abstract] [Full-text]
32. The high prevalence of bipolar spectrum disorders in young adults with recurrent depression: toward an innovative diagnostic framework.
    J Affect Disord, 84(2): 167-78. [Abstract] [Full-text]
33. Profiles of "manic" symptoms in bipolar I, bipolar II and major depressive disorders.
    J Affect Disord, 84(2): 159-66. [Abstract] [Full-text]
34. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions.
    J Affect Disord, 84(2): 149-57. [Abstract] [Full-text]
35. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression.
    J Affect Disord, 84(2): 141-7. [Abstract] [Full-text]
36. Dimensional psychopathology of depression: detection of an 'activation' dimension in unipolar depressed outpatients.
    J Affect Disord, 84(2): 133-9. [Abstract] [Full-text]
37. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures.
    J Affect Disord, 84(2): 127-32. [Abstract] [Full-text]
38. A different depression: clinical distinctions between bipolar and unipolar depression.
    J Affect Disord, 84(2): 117-25. [Abstract] [Full-text]
39. The dark side of bipolarity: detecting bipolar depression in its pleomorphic expressions.
    J Affect Disord, 84(2): 107-15. [Abstract] [Full-text]
40. Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study.
    Psychiatry Res, 138(1): 43-9. [Abstract] [Full-text]
41. Characterization of human and mouse TRPM2 genes: identification of a novel N-terminal truncated protein specifically expressed in human striatum.
    Biochem Biophys Res Commun, 328(4): 1232-43. [Abstract] [Full-text]
42. Bipolar disorder: an update.
    Neurochem Int, 46(4): 273-9. [Abstract] [Full-text]
43. Alteration of lithium pharmacology through manipulation of phosphoadenosine phosphate metabolism.
    J Biol Chem, 280(7): 5400-5. [Abstract] [Full-text]
44. Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?
    Eur Arch Psychiatry Clin Neurosci, 255(1): 72-4. [Abstract] [Full-text]
45. Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes.
    Eur Arch Psychiatry Clin Neurosci, 255(1): 65-71. [Abstract] [Full-text]
46. Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy.
    J Abnorm Psychol, 114(1): 170-5. [Abstract] [Full-text]
47. Low doses of clozapine may stabilize treatment-resistant bipolar patients.
    Eur Arch Psychiatry Clin Neurosci, 255(1): 10-4. [Abstract] [Full-text]
48. The spectrum of substance use in mood and anxiety disorders.
    Compr Psychiatry, 46(1): 6-13. [Abstract] [Full-text]
49. Use of seclusion in a psychiatric acute inpatient unit.
    Australas Psychiatry, 12(4): 347-51. [Abstract] [Full-text]
50. Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid.
    Neuropsychopharmacology, 30(3): 461-72. [Abstract] [Full-text]
51. A case of seasonal bipolar disorder exacerbated by Cushing's disease.
    Compr Psychiatry, 46(2): 155-8. [Abstract] [Full-text]
52. The childhood-onset neuropsychiatric background to adulthood psychopathic traits and personality disorders.
    Compr Psychiatry, 46(2): 111-6. [Abstract] [Full-text]
53. Care satisfaction, hope, and life functioning among adults with bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program.
    Compr Psychiatry, 46(2): 98-104. [Abstract] [Full-text]
54. Visual motion integration in schizophrenia patients, their first-degree relatives, and patients with bipolar disorder.
    Schizophr Res, 74(2): 271-81. [Abstract] [Full-text]
55. Association of symptoms and executive function in schizophrenia and bipolar disorder.
    Schizophr Res, 74(2): 221-31. [Abstract] [Full-text]
56. General-medical conditions in older patients with serious mental illness.
    Am J Geriatr Psychiatry, 13(3): 250-4. [Abstract] [Full-text]
57. Steroid dementia: an overlooked diagnosis?
    Neurology, 64(4): 707-9. [Abstract] [Full-text]
58. Screening for bipolar disorder in a primary care practice.
    JAMA, 293(8): 956-63. [Abstract] [Full-text]
59. Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: Another clinical report and a review of the literature.
    Am J Med Genet A, 132(4): 441-4. [Abstract] [Full-text]
60. A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.
    Hum Psychopharmacol, 20(2): 133-9. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.